Synthesis of peptides
    51.
    发明授权
    Synthesis of peptides 失效
    肽的合成

    公开(公告)号:US4301045A

    公开(公告)日:1981-11-17

    申请号:US792524

    申请日:1977-05-02

    摘要: Resin peptides useful in the preparation of peptides having biological activity, and particularly such resin peptides containing Pro--Asp--CH.sub.2 -- or Pro--Asn--CH.sub.2 -- at one end of an amino acid chain, being the resin and Pro, Asp and Asn being the residues of the amino acids proline, aspartic acid and asparagine; and processes for the preparation of such resin peptides.

    摘要翻译: 可用于制备具有生物活性的肽的树脂肽,特别是在氨基酸链的一端含有Pro-Asp-CH2-或Pro-Asn-CH2-的树脂肽是树脂,Pro,Asp和Asn是 氨基酸脯氨酸,天冬氨酸和天冬酰胺的残基; 以及制备这种树脂肽的方法。

    Synthesis of peptides
    52.
    发明授权
    Synthesis of peptides 失效
    肽的合成

    公开(公告)号:US4130514A

    公开(公告)日:1978-12-19

    申请号:US876752

    申请日:1978-02-10

    摘要: Peptides having adrenocorticotropic hormone activity and resin peptides useful in preparation of such peptides, particularly such peptides having asparagine at the carboxyl end thereof and more particularly such peptides having from 19 to 25 amino acids in their amino acid chains. The invention further involves new processes for the preparation of such peptides.

    摘要翻译: 具有促肾上腺皮质激素活性的肽和可用于制备这些肽的树脂肽,特别是在其羧基末端具有天冬酰胺的肽,更特别是在其氨基酸链中具有19至25个氨基酸的肽。 本发明还涉及制备这些肽的新方法。

    Psychopharmacologically active peptides and peptide-derivatives, and the
use thereof
    53.
    发明授权
    Psychopharmacologically active peptides and peptide-derivatives, and the use thereof 失效
    精神药理活性肽和肽衍生物及其用途

    公开(公告)号:US4104371A

    公开(公告)日:1978-08-01

    申请号:US811859

    申请日:1977-06-30

    摘要: Biologically active novel peptides and peptide-derivatives of the general formula: ##STR1## where A represents H-(L or D)Met, H-(L or D)Met(.fwdarw.O), H-(L or D)Met(.fwdarw.O.sub.2)desamino-Met, desamino-Met(.fwdarw.O),desamino-Met(.fwdarw.O.sub.2) or the group H.sub.2 N--B--CO--;B represents a branched or straight-chain alkylene (C.sub.1 -C.sub.6) or alkylidene (C.sub.1 -C.sub.6) group;Q represents the amino-acid residue --NH--CHR--CO--;R represents alkyl (C.sub.1 -C.sub.6), p-hydroxyphenylmethyl, 3-indolylmethyl or phenylmethyl;R.sub.1 and R.sub.2 represent hydrogen or an alkyl(1-6C) group, andZ represents N-(phenylalkyl)amino, N-(.beta.-indolylalkyl)amino, L-Trp-OH, L-Phe-OH, L-Trp-Gly-OH or L-Phe-Gly-OH, as well as the functional derivatives thereof.

    摘要翻译: 生物活性的新型肽和肽衍生物,通式如下:其中A表示H-(L或D)Met,H-(L或D)Met( - > O),H-(L或D) ( - > O 2)desamino-Met,desamino-Met( - > O),desamino-Met( - > O 2)或H 2 N-B-CO-基团; B表示支链或直链亚烷基(C1-C6)或亚烷基(C1-C6)基团; Q表示氨基酸残基-NH-CHR-CO-; R代表烷基(C1-C6),对羟基苯基甲基,3-吲哚基甲基或苯基甲基; R 1和R 2表示氢或烷基(1-6C)基团,Z表示N-(苯基烷基)氨基,N-(β-吲哚基烷基)氨基,L-Trp-OH,L-Phe-OH,L-Trp- Gly-OH或L-Phe-Gly-OH,以及其功能衍生物。

    (1-{60 -Aminoisobutyric acid)-corticotropin peptides
    56.
    发明授权
    (1-{60 -Aminoisobutyric acid)-corticotropin peptides 失效
    (1- {60-氨基丁酸)促皮质素肽

    公开(公告)号:US3873511A

    公开(公告)日:1975-03-25

    申请号:US12454971

    申请日:1971-03-15

    申请人: SHIONOGI & CO

    摘要: Highly active corticotropin peptides which have an Alpha aminoisobutyric acid residue at the amino-terminal in place of the serine in native corticotropin, derivatives thereof, intermediates therefor and compositions thereof are disclosed. Such peptides are useful as a medicament, because they show corticotropic properties remarkably improved in enhancement of potency and prolongation of action. They can be prepared by condensing the amino acids together one by one or by condensing the small peptide fragments together in a per se conventional manner.

    摘要翻译: 公开了在天然促肾上腺皮质激素,其衍生物,其中间体及其组合物中在氨基末端具有α-氨基异丁酸残基代替丝氨酸的高活性促肾上腺皮质激素肽。 这样的肽可用作药物,因为它们显示出在提高效力和作用延长方面显着改善的皮质醇性质。 它们可以通过将氨基酸一个一个地缩合在一起,或者通过将这些小肽片段以本来常规的方式一起冷凝来制备。

    D-ser1-nle4-lys17-lys18-val-nh2 25-alpha-1-25 acth and derivatives thereof
    59.
    发明授权
    D-ser1-nle4-lys17-lys18-val-nh2 25-alpha-1-25 acth and derivatives thereof 失效
    D-SER1-NLE4-LYS17-LYS18-VAL-NH2 25-ALPHA-1-25其衍生物及其衍生物

    公开(公告)号:US3761461A

    公开(公告)日:1973-09-25

    申请号:US3761461D

    申请日:1967-01-10

    申请人: SANDOZ LTD

    摘要: THE PRESENT INVENTION PROVIDES THE PENTACOSAPERPTIDES OF GENERAL FORMULA D-SERYL-L-TYROSYL-L-SERYL-L-NORLENCYLX-L-HISTIDYL-L-PHENYLALANYL-L-ARGINYL-L-TRYPTOPHANYL-GLYCYL-L-LYSYL-L-PROTYL-L-VALYL-GLYCYLL-LYSYL-L-LLYSYL-L-LYSYL-L-LYSYL-L-PROLYL-LVALYL-L-LYSYL-L-VALYL-L-TYROSYL-L-PROLYL-L-VALINAMIDE, IN WHICH X SIGNIFIES AN L-GLUTAMYL OR L-GLUTAMINYL RADICAL, THEIR THERAPEUTICALLY ACTIVE ACID ADDITION SALTS AND HEAVY METAL COMPLEXES. THE PENTACOSAPEPTIDES OF THE ABOVE FORMULA, THEIR SALTS AND HEAVY METAL COMPLEXES EXHIBIT A HIGH ADRENOCORTICOTROPIC EFFECT. THE PRODUCTION OF THESE PEPTIDES IS FURTHERMORE DESCRIBED.

    (1-beta-alanine,15-ornithine)-corticotropin peptides
    60.
    发明授权
    (1-beta-alanine,15-ornithine)-corticotropin peptides 失效
    (1-BETA-ALANINE,15-ORNITHINE)-CORTICOTROPIN PEPTIDES

    公开(公告)号:US3759891A

    公开(公告)日:1973-09-18

    申请号:US3759891D

    申请日:1971-03-22

    申请人: SHIONOGI & CO

    发明人: OTSUKA H INOUYE K

    摘要: CORTICOTROPICALLY ACTIVE OCTADECAPEPTIDES WHEREIN THE FIRST AMINO ACID, SERINE, AND THE FIFTEENTH AMINO ACID, LYSINE, IN THE NATIVE CORTICOTROPIN MOLECULE ARE SUBSTITUTED RESPECTIVELY BY B-ALANINE AND ORNITHINE, DERIVATIVES THEREOF, NON-TOXIC ACID ADDITION SALTS THEREOF AND COMPLEXES THEREOF ARE DISCLOSED. SUCH PEPTIDES ARE USEFUL AS A MEDICAMENT, BECAUSE THEY SHOW CORTICOTROPIC PROPERTIES REMARKABLY IMPROVED IN PROLONGATION OF ACTION. THEY CAN BE PREPARED BY CONDENSING THE AMINO ACIDS TOGETHER ONE BY ONE OR BY CONDENSING THE SMALL PEPTIDE FRAGMENTS TOGETHER IN A PER SE CONVENTIONAL MANNER.